Product
AD-208
1 clinical trial
1 indication
Indication
Androgenetic AlopeciaClinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AD-208 in Male Patients With Androgenetic AlopeciaStatus: Completed, Estimated PCD: 2023-01-09